SXTC
China Sxt Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$2.34
−3.90%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$2.39
From 52W high−99.99%
Volume51048.00
Market cap$3.09M
P/E (TTM)—
P/S (TTM)2.9x
Div yield—
Key dataSep 18, 2026
Open
$2.39
From 52W high
−99.99%
Volume
51048.00
Market cap
$3.09M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
3.4x
P/E (TTM)
—
RSI (14)
25.4
MomentumView details →
1D Return
−3.90%
YTD Return
−99.99%
SummaryUpdated Mar 1, 2026
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) is a Chinese pharmaceutical company founded in 2005 and headquartered in Taizhou, China. The company went public on the NASDAQ in January 2019. SXT specializes in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP), operating primarily within China's healthcare market. The company has experienced significant financial volatility in recent years, with fluctuating revenues and alternating periods of profitability and losses.
Similar companies
Latest newsMore news →